Skip to main content
RemeGen Co., Ltd. logo

RemeGen Co., Ltd. — Investor Relations & Filings

Ticker · 9995 ISIN · CNE1000048G6 LEI · 300300M9HCX4TFAD4I10 HKEX Manufacturing
Open in API
Filings indexed 1,624 across all filing types
Latest filing 2024-02-01 Regulatory Filings
Country CN China
Listing HKEX 9995

About RemeGen Co., Ltd.

http://www.remegen.com

RemeGen Co., Ltd. is a biopharmaceutical company dedicated to the discovery, development, production, and commercialization of innovative biological drugs. The company focuses on creating first-in-class and best-in-class therapeutics to address significant unmet clinical needs, particularly in the critical therapeutic areas of autoimmune diseases, oncology, and ophthalmology. RemeGen utilizes proprietary technology platforms capable of discovering, screening, and developing new molecules and efficiently optimizing production processes. Its pipeline includes a series of innovative biologics, such as Telitacicept, and features 8 clinical pipelines, over 40 clinical trials, and more than 600 patent applications, demonstrating a strong commitment to R&D and innovation in biopharmaceuticals.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movement in Securities for the month ended 31 January 2024
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 January 2024. It details movements in authorised/registered share capital, issued shares, and confirms compliance with listing rules. There are no financial statements or earnings data, nor is it an announcement of voting results or management changes. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited regarding share capital and securities movements, fitting the description of a general regulatory announcement. It does not contain or announce a full report, nor is it a certification letter or a short announcement of a report publication. Therefore, it best fits the category of Regulatory Filings (RNS).
2024-02-01 English
INSIDE INFORMATION-ESTIMATED 2023 ANNUAL RESULTS
Earnings Release Classification · 95% confidence The document is an announcement by RemeGen Co., Ltd. regarding its estimated 2023 annual results. It explicitly states that the financial data is preliminary, unaudited, and subject to change in the final annual report. The document includes estimated revenue, net loss, and explanations for changes compared to the previous year. It also contains a risk warning and advises investors to await the official audited annual report. The document is relatively short (5183 characters) and serves as an inside information announcement of estimated results rather than the full annual report itself. According to the 'Menu vs Meal' rule, this is an announcement of estimated results, not the full official annual report (10-K). Therefore, the appropriate classification is Earnings Release (ER), which covers initial announcements of quarterly or periodical financial results with key highlights only, including estimated annual results. FY 2023
2024-01-30 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-01-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-01-25 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2024-01-22 English
VOLUNTARY ANNOUNCEMENT-SHARE PURCHASE PURSUANT TO THE SECOND H SHARE AWARD AND TRUST SCHEME
Transaction in Own Shares Classification · 95% confidence The document is a voluntary announcement by RemeGen Co., Ltd. regarding the purchase of shares pursuant to the Second H Share Award and Trust Scheme. It details the number of shares purchased, purchase price range, total consideration, and mentions that no shares have yet been granted under the scheme. The announcement also states that further updates may be made on the status of the scheme. The document is relatively short (2714 characters) and serves as an update on share purchases related to an employee incentive plan. It is not a full financial report, earnings release, or management discussion. It is also not a regulatory certification or a report publication announcement. The content fits best under the category of Transaction in Own Shares (POS), which covers company buybacks or share purchases related to incentive schemes.
2024-01-22 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.